Biosurgery Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product Type (Anti-Adhesive Agents, Hemostatic Agents, Surgical Sealing Agents, Bone Graft Substitutes, Soft Tissue Attachments), By Application (Cardiovascular And Thoracic Surgery, Neuro-Spine Surgery, Orthopedic Surgery, General Surgery, Others), By Source (Natural/Biological Products, Synthetic Products), And By Geography - Forecasts From 2022 To 2027

Published:  Mar 2022 Report Code: KSI061611887 Pages: 124

The Global Biosurgery Market is evaluated at US$3.042 billion for the year 2020, growing at a CAGR of 5.27% to reach the market size of US$4.357 billion by the year 2027.

The global biosurgery market comprises certain products used to minimize or reduce intra- and post-surgery complications. Biosurgery products offer more efficiency and less complexity in surgery and other medical procedures. Depending on the types of products, the biosurgery market is segmented into certain types like hemostatic, anti-adhesive agents, surgical sealing agents, and bone graft substitutes.  The rising number of surgery cases and increasing geriatric population is giving potential to the market growth of global biosurgery products. The population aged 65 and above or the geriatric population is widely using the help and assistance of biosurgery products. The wide application of biosurgery products in medical and surgical procedures in the geriatric population raises the demand for biosurgery products in the global market. The rising cases of surgery and operation procedures due to chronic diseases and sports surgeries are also driving the market growth of the global biosurgery market. The higher investments of major companies in the research and development section of biosurgery products also result in major developments and advancements in biosurgery products. The government's support in new advanced research and developments in biosurgery products is also boosting the global biosurgery products market. The growth and adaptation of technology in the medical field increase the global biosurgery market.

The recent outbreak of the COVID-19 pandemic has restricted the market growth of the global biosurgery market to a certain extent. The pandemic fear had made the patients have less interaction with hospitals and health centers.  The fear of people visiting hospitals and clinics for certain medical procedures other than COVID resulted in the slow market growth of the global biosurgery market. The home-based health diagnosis and check-ups resulted in the restricted market growth of the global biosurgery market. The full focus of government agencies and major companies in developing and preventing COVID spread also restricted the fast growth of the research and development section of biosurgery products in the global market.

Rising Research and Development Programmes  

The higher investments of major players or companies in the research and development sector of biosurgery products are boosting the market growth of the global biosurgery market. The penetration of technology or electronics in the field of biosurgery has boosted the market growth of the global biosurgery market to a certain extent. The development of advanced infused bone graft implantation developed by Medtronic PLC can be considered as one of the rising developments in the field of bone graft implantation or biosurgery products. The approval of the FDA (U.S Food and Drug Administration) for the newly developed bone graft implantation also shows the immense support of governmental agencies in the development of biosurgery products. The synthetic hydrogel technology developed by Kuros Biosurgery can also be counted as one of the major developments in the global biosurgery market. The rapid growth in the research and development sector of biosurgery products is fuelling the market growth of the global biosurgery market. The increased penetration of electronics and new technology in the medical field also resulted in new advancements and developments in the global biosurgery market. The higher competition of major players in the research and development sector of biosurgery products contributes to the rapid growth of biosurgery products in the global market.  

Rising number of surgeries & cases of chronic diseases

The rising number of surgeries and an increasing number of people with chronic diseases is one of the major factors driving the market growth of the global biosurgery market. The convenience and effectiveness offered by biosurgery products result in the market growth of biosurgery products. The increasing cases of chronic diseases are contributing to the market growth of the global biosurgery market. The rising cases of cardiovascular diseases and implementation of biosurgery products in surgeries and treatment of cardiovascular diseases is giving potential to the market growth of the global biosurgery market. The surgeries and implantations in cardiovascular diseases are the major sections that widely employ the application of biosurgery products in the medical field. The rising percentage of the geriatric population is also one of the major driving factors in the growth of the global biosurgery market. The report of the United Nations states that approximately 962 million people are aged 60 or above in the world. The population growth rate of people above 60 also reports a growth rate of 3% annually. The rise in the geriatric population and increasing cases of lifestyle and chronic diseases are fuelling the growth of the global biosurgery market.

North America expected to lead the market  

Geographically, the North American region is expected to lead the global biosurgery market in the forecasted years. The rising cases of chronic and lifestyle diseases and obesity problems are driving the market growth of the biosurgery market in the North American region. The presence of major players and the investment and research & development of biosurgery products is also hiking the market of biosurgery products in the North American region.

Biosurgery Market Scope:

Report Metric Details
 Market size value in 2020  US$3.042 billion
 Market size value in 2027  US$4.357 billion
 Growth Rate  CAGR of 5.27% from 2020 to 2027
 Base year  2020
 Forecast period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments covered  Product Type, Application, Source, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Baxter International Inc., Johnson &Johnson, Becton Dickinson and Company, B. Braun Melsungen AG, CryoLife, Inc., Atrium Medical, Haemostasis LLC, Sanofi, Medtronic PLC, Kuros Bioscience
 Customization scope  Free report customization with purchase

 

Segmentation

  • By Product Type
    • Anti-adhesive agents
    • Hemostatic agents
    • Surgical sealing agents
    • Bone graft substitutes
    • Soft Tissue Attachments
  • By Application
    • Cardiovascular and Thoracic Surgery
    • Neuro-Spine surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Source
    • Natural/Biological Products
    • Synthetic Products
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the biosurgery market size by 2027?
A1. The global biosurgery market is projected to reach a total market size of US$4.357 billion by 2027. 


Q2. What is the size of the global biosurgery market?
A2. Biosurgery Market was valued at US$3.042 billion in 2020. 


Q3. What are the growth prospects for the biosurgery market?
A3. The biosurgery market is projected to grow at a CAGR of 5.27% during the forecast period. 


Q4. Which region holds the largest market share in the biosurgery market?
A4. The North American region is expected to lead the global biosurgery market owing to the rising cases of chronic diseases, lifestyle diseases, and obesity problems.


Q5. What factors are anticipated to drive the biosurgery market growth?
A5. The rising number of surgery cases and increasing geriatric population is giving potential to the biosurgery market growth.

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Global Biosurgery Market Analysis, by Product Type
5.1. Introduction
5.2. Anti-adhesive agents
5.3. Hemostatic agents 
5.4. Surgical sealing agents
5.5. Bone graft substitutes
5.6. Soft Tissue attachments 

6. Global Biosurgery Market Analysis, by Application 
6.1. Introduction
6.2. Cardiovascular and Thoracic Surgery
6.3. Neuro-Spine surgery
6.4. Orthopedic Surgery 
6.5. General Surgery
6.6. Others

7. Global Biosurgery Market Analysis, by Source
7.1. Introduction
7.2. Natural/Biological Products
7.3. Synthetic Products

8. Global Biosurgery Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. UK
8.4.4. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others

9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. Company Profiles 
10.1. Baxter International Inc. 
10.2. Johnson &Johnson 
10.3. Becton Dickinson and Company
10.4. B. Braun Melsungen AG
10.5. CryoLife, Inc.
10.6. Atrium Medical
10.7. Haemostasis LLC
10.8. Sanofi
10.9. Medtronic PLC 
10.10. Kuros Bioscience 

Baxter International Inc.

Johnson &Johnson

Becton Dickinson and Company

B. Braun Melsungen AG

CryoLife, Inc.

Atrium Medical

Haemostasis LLC

Sanofi

Medtronic PLC

Kuros Bioscience

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us